BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 18301055)

  • 21. Chordoma: Immunohistochemical Analysis of Brachury.
    Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
    Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extra-axial chordoma presenting as a lung mass.
    Park SY; Kim SR; Choe YH; Lee KY; Park SJ; Lee HB; Jin GY; Jang KY; Lee YC
    Respiration; 2009; 77(2):219-23. PubMed ID: 18497501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classic chordoma coexisting with benign notochordal cell rest demonstrating different immunohistological expression patterns of brachyury and galectin-3.
    Shen J; Li CD; Yang HL; Lu J; Zou TM; Wang DL; Deng M
    J Clin Neurosci; 2011 Jan; 18(1):96-9. PubMed ID: 20855213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical distinction of classic and chondroid chordomas.
    Walker WP; Landas SK; Bromley CM; Sturm MT
    Mod Pathol; 1991 Sep; 4(5):661-6. PubMed ID: 1722044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of brachyury in hemangioblastoma: potential use in differential diagnosis.
    Barresi V; Vitarelli E; Branca G; Antonelli M; Giangaspero F; Barresi G
    Am J Surg Pathol; 2012 Jul; 36(7):1052-7. PubMed ID: 22446946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extra-axial chordoma.
    DiFrancesco LM; Davanzo Castillo CA; Temple WJ
    Arch Pathol Lab Med; 2006 Dec; 130(12):1871-4. PubMed ID: 17149966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parachordoma of the buttock: an immunohistochemical case study and review.
    Hirokawa M; Manabe T; Sugihara K
    Jpn J Clin Oncol; 1994 Dec; 24(6):336-9. PubMed ID: 7530308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parachordoma. A case report of a very rare soft tissue tumor.
    Karabela-Bouropoulou V; Skourtas C; Liapi-Avgeri G; Mahaira H
    Pathol Res Pract; 1996 Sep; 192(9):972-8; discussion 979-81. PubMed ID: 8950765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant myoepithelial tumor of soft tissue: a report of two cases of the lower extremity and a review of the literature.
    Lee JR; Georgi DE; Wang BY
    Ann Diagn Pathol; 2007 Jun; 11(3):190-8. PubMed ID: 17498593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent skeletal extra-axial chordoma confirmed with brachyury: imaging features and review of the literature.
    Lantos JE; Agaram NP; Healey JH; Hwang S
    Skeletal Radiol; 2013 Oct; 42(10):1451-9. PubMed ID: 23653219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.
    Sangoi AR; Karamchandani J; Lane B; Higgins JP; Rouse RV; Brooks JD; McKenney JK
    Mod Pathol; 2011 Mar; 24(3):425-9. PubMed ID: 21102418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extra-axial chordoma of the gingiva.
    Ueda T; Kubota K; Shiroma N; Maeda S; Furuie H; Taruya T; Hamamoto T; Takeno S
    Auris Nasus Larynx; 2020 Apr; 47(2):299-304. PubMed ID: 30904199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathology of myxoid bone tumors of the skull base].
    Gavril C; Bouvier C; Liprandi A; Dufour H; Peragut JC; Zanaret M; Figarella-Branger D
    Ann Pathol; 2002 Sep; 22(4):259-66. PubMed ID: 12410148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastases to soft tissue: a review of 118 cases over a 30-year period.
    Plaza JA; Perez-Montiel D; Mayerson J; Morrison C; Suster S
    Cancer; 2008 Jan; 112(1):193-203. PubMed ID: 18040999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brachyury and chordoma: the chondroid-chordoid dilemma resolved?
    Romeo S; Hogendoorn PC
    J Pathol; 2006 Jun; 209(2):143-6. PubMed ID: 16604512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of brachyury expression in chordomas.
    Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
    Ann Diagn Pathol; 2021 Aug; 53():151760. PubMed ID: 33989961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.